_id

690db661ccc777a4e85d0e25

Ticker

BDTX

Name

Black Diamond Therapeutics Inc

Exchange

NASDAQ

Address

One Main Street, Cambridge, MA, United States, 02142

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.blackdiamondtherapeutics.com

Description

Black Diamond Therapeutics, Inc., a clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. The company's lead product candidate is BDTX-1535, a brain-penetrant epidermal growth factor receptor MasterKey inhibitor, which is in Phase 2 clinical trial for the treatment of epidermal growth factor receptor mutant non-small cell lung cancer, as well as Phase 1 clinical trial to treat glioblastoma. It is also developing BDTX-4933, a brain-penetrant RAF MasterKey inhibitor targeting KRAS, NRAS, and BRAF alterations in solid tumors that is in Phase 1 clinical trial. In addition, the company is developing BDTX-4876, a MasterKey inhibitor of oncogenic FGFR2/3 mutations with selectivity versus FGFR1/4, which is in preclinical stage. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Last Close

2.71

Volume

845219

Current Price

2.67

Change

-1.4760147601476028

Last Updated

2025-11-28T12:48:00.857Z

Image

data:image/webp;base64,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

Ipo Date

2020-01-30T00:00:00.000Z

Market Cap

215365168

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.8668333333333335

Sentiment Sources

6

Rating

4.75

Target Price

9

Strong Buy

3

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

10978000

Operating Income

-10978000

Interest Expense

-

Pretax Income

-8498000

Net Income

-8498000

Eps

-0.14927338658401135

Dividends Per Share

-

Shares Outstanding

56974913

Income Tax Expense

-

EBITDA

-8412000

Operating Margin

-

Total Other Income Expense Net

2480000

Cash

30864000

Short Term Investments

104639000

Receivables

-

Inventories

-

Total Current Assets

138992000

Property Plant Equipment

17797000

Total Assets

157733000

Payables

975000

Short Term Debt

-

Long Term Debt

-

Total Liabilities

31581000

Equity

126152000

Depreciation

86000

Change In Working Capital

-1879000

Cash From Operations

-7850000

Capital Expenditures

0

Cash From Investing

8590000

Cash From Financing

134000

Net Change In Cash

874000

PE

10.2162

PB

1.204901269975902

ROE

-6.736318092459889

ROA

-5.387585349926774

FCF

-7850000

Fcf Percent

-

Piotroski FScore

1

Health Score

43

Deep Value Investing Score

5.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

4.5

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

8

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

10978000

Quarters > 0 > income Statement > operating Income

-10978000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-8498000

Quarters > 0 > income Statement > net Income

-8498000

Quarters > 0 > income Statement > eps

-0.14927338658401135

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

56929103

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-8412000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

2480000

Quarters > 0 > balance Sheet > cash

30864000

Quarters > 0 > balance Sheet > short Term Investments

104639000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

138992000

Quarters > 0 > balance Sheet > property Plant Equipment

17797000

Quarters > 0 > balance Sheet > total Assets

157733000

Quarters > 0 > balance Sheet > payables

975000

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

31581000

Quarters > 0 > balance Sheet > equity

126152000

Quarters > 0 > cash Flow > net Income

-8498000

Quarters > 0 > cash Flow > depreciation

86000

Quarters > 0 > cash Flow > change In Working Capital

-1879000

Quarters > 0 > cash Flow > cash From Operations

-7850000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

8590000

Quarters > 0 > cash Flow > cash From Financing

134000

Quarters > 0 > cash Flow > net Change In Cash

874000

Quarters > 0 > ratios > PE

-0.14927338658401135

Quarters > 0 > ratios > PB

1.204901269975902

Quarters > 0 > ratios > ROE

-6.736318092459889

Quarters > 0 > ratios > ROA

-5.387585349926774

Quarters > 0 > ratios > FCF

-7850000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

43

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

86000

Quarters > 1 > income Statement > gross Profit

-86000

Quarters > 1 > income Statement > operating Expenses

13334000

Quarters > 1 > income Statement > operating Income

-13420000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-10561000

Quarters > 1 > income Statement > net Income

-10561000

Quarters > 1 > income Statement > eps

-0.18592180580580933

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

56803450

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-10475000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

2859000

Quarters > 1 > balance Sheet > cash

29993000

Quarters > 1 > balance Sheet > short Term Investments

112836000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

146726000

Quarters > 1 > balance Sheet > property Plant Equipment

18674000

Quarters > 1 > balance Sheet > total Assets

166385000

Quarters > 1 > balance Sheet > payables

771000

Quarters > 1 > balance Sheet > short Term Debt

3782000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

33775000

Quarters > 1 > balance Sheet > equity

132610000

Quarters > 1 > cash Flow > net Income

-10561000

Quarters > 1 > cash Flow > depreciation

86000

Quarters > 1 > cash Flow > change In Working Capital

-805000

Quarters > 1 > cash Flow > cash From Operations

-9159000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-59153000

Quarters > 1 > cash Flow > cash From Financing

-116000

Quarters > 1 > cash Flow > net Change In Cash

-68428000

Quarters > 1 > ratios > PE

-0.18592180580580933

Quarters > 1 > ratios > PB

1.1436936241610738

Quarters > 1 > ratios > ROE

-7.963954452907021

Quarters > 1 > ratios > ROA

-6.347326982600595

Quarters > 1 > ratios > FCF

-9159000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

43

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

70000000

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

70000000

Quarters > 2 > income Statement > operating Expenses

15470000

Quarters > 2 > income Statement > operating Income

54530000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

56542000

Quarters > 2 > income Statement > net Income

56542000

Quarters > 2 > income Statement > eps

0.9803877540896493

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

57673099

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

54617000

Quarters > 2 > income Statement > operating Margin

77.9

Quarters > 2 > income Statement > total Other Income Expense Net

2012000

Quarters > 2 > balance Sheet > cash

98424000

Quarters > 2 > balance Sheet > short Term Investments

53976000

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

155679000

Quarters > 2 > balance Sheet > property Plant Equipment

19540000

Quarters > 2 > balance Sheet > total Assets

176245000

Quarters > 2 > balance Sheet > payables

2628000

Quarters > 2 > balance Sheet > short Term Debt

3705000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

34729000

Quarters > 2 > balance Sheet > equity

141516000

Quarters > 2 > cash Flow > net Income

56542000

Quarters > 2 > cash Flow > depreciation

87000

Quarters > 2 > cash Flow > change In Working Capital

-5260000

Quarters > 2 > cash Flow > cash From Operations

53410000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

8547000

Quarters > 2 > cash Flow > cash From Financing

32000

Quarters > 2 > cash Flow > net Change In Cash

61989000

Quarters > 2 > ratios > PE

0.9803877540896493

Quarters > 2 > ratios > PB

1.088125542906809

Quarters > 2 > ratios > ROE

39.954492778201754

Quarters > 2 > ratios > ROA

32.08147748872309

Quarters > 2 > ratios > FCF

53410000

Quarters > 2 > ratios > Piotroski FScore

3

Quarters > 2 > ratios > fcf Percent

0.763

Quarters > 2 > health Score

93

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

516000

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

258000

Quarters > 3 > income Statement > operating Expenses

18275000

Quarters > 3 > income Statement > operating Income

-18275000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-15985000

Quarters > 3 > income Statement > net Income

-15985000

Quarters > 3 > income Statement > eps

-0.2823813704115412

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

56607842

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-18190000

Quarters > 3 > income Statement > operating Margin

-3541.6666666666665

Quarters > 3 > income Statement > total Other Income Expense Net

2290000

Quarters > 3 > balance Sheet > cash

36437000

Quarters > 3 > balance Sheet > short Term Investments

62138000

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

101176000

Quarters > 3 > balance Sheet > property Plant Equipment

20396000

Quarters > 3 > balance Sheet > total Assets

122640000

Quarters > 3 > balance Sheet > payables

4007000

Quarters > 3 > balance Sheet > short Term Debt

3404000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

39355000

Quarters > 3 > balance Sheet > equity

83285000

Quarters > 3 > cash Flow > net Income

-15985000

Quarters > 3 > cash Flow > depreciation

85000

Quarters > 3 > cash Flow > change In Working Capital

-816000

Quarters > 3 > cash Flow > cash From Operations

-15055000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

27769000

Quarters > 3 > cash Flow > cash From Financing

291000

Quarters > 3 > cash Flow > net Change In Cash

13005000

Quarters > 3 > ratios > PE

-0.2823813704115412

Quarters > 3 > ratios > PB

1.81476782301735

Quarters > 3 > ratios > ROE

-19.19313201656961

Quarters > 3 > ratios > ROA

-13.034083496412263

Quarters > 3 > ratios > FCF

-15055000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-29.176356589147286

Quarters > 3 > health Score

35

Valuation > metrics > PE

10.2162

Valuation > metrics > PB

1.204901269975902

Valuation > final Score

100

Valuation > verdict

Fair

Profitability > metrics > ROE

-6.736318092459889

Profitability > metrics > ROA

-6.114020950846092

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.2503408586467119

Risk > metrics > Interest Coverage

-127.65116279069767

Risk > final Score

-451

Risk > verdict

High

Liquidity > metrics > Current Ratio

142.55589743589744

Liquidity > metrics > Quick Ratio

142.55589743589744

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

100

Prev Valuations > 2

80

Prev Profitabilities > 0

15

Prev Profitabilities > 1

100

Prev Profitabilities > 2

0

Prev Risks > 0

-564

Prev Risks > 1

100

Prev Risks > 2

27

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-12T00:09:59.717Z